Author

Michael Vieth 1

1 Klinikum Bayreuth, Bayreuth, Germany

A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, EUROPEAN MULTICENTRE TRIAL OF TWO NEW BUDESONIDE FORMULATIONS FOR TREATMENT OF ACTIVE EOSINOPHILIC ESOPHAGITIS

Petr Hruz, Stephan Miehlke, Ulrike von Arnim, Ahmed Madisch, Michael Vieth, Christiane Fibbe, Henning Wittenburg, Hans-Dieter Allescher, Max Reinshagen, Stefan Schubert, Jan Tack, Michaela Müller, Alexander J. Eckardt, Patrick Krummenerl, Joris Arts, Karin Dilger, Roland Greinwald, Alex Straumann

Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Pedro Pimentel-Nunes, Mario Dinis-Ribeiro, Thierry Ponchon, Alessandro Repici, Michael Vieth, Antonella De Ceglie, Arnaldo Amato, Frieder Berr, Pradeep Bhandari, Andrzej Bialek, Massimo Conio, Jelle Haringsma, Cord Langner, Soren Meisner, Helmut Messmann, Mario Morino, Horst Neuhaus, Hubert Piessevaux, Massimo Rugge, Bri

Is biopsy essential for the diagnosis of inflammatory bowel disease only affecting the small bowel?

Michael Vieth

European consensus on the histopathology of inflammatory bowel disease

Fernando Jose Magro Dias, Cord Langner, Ann Driessen, Arzu Ensari, Karel Geboes, Gerassimos J. Mantzaris, Vincenzo Villanacci, Gabriel Becheanu, Paula Borralho-Nunes, G Cathomas, Walter Fries, Anne Jouret-Mourin, Claudia Mescoli, G de Petris, C.A. Rubio, N Shepherd, Michael Vieth, Abraham (Rami) Eliakim

DISTRIBUTION OF DIAGNOSTIC CRITERIA FOR COLLAGENOUS COLITIS – POOLED ANALYSIS OF 2 EUROPEAN CLINICAL TRIALS

Stephan Miehlke, Daniela Aust, Ole Kristian Bonderup, Johan Bohr, Ahmed Madisch, Michael Vieth, Henrik Hjortswang, Fernando Fernández-Bañares, Curt Tysk, Magnus Strom, Ralph Mueller, Roland Greinwald, Andreas Münch, Ralf Mohrbacher

DKK-2, A MODULATOR OF WNT-SIGNALING PATHWAY, IS OVEREXPRESSED IN GASTRIC CANCER

Michael Selgrad, Jan Bornschein, Michael Vieth, Peter Malfertheiner

Budesonide orodispersible tablets are superior to maintain combined clinical and histological remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Luc Biedermann, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Stefan Schubert, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen

A novel budesonide orodispersible tablet with a special esophageal-targeting can induce complete clinical, endoscopic and histologic remission in active Eosinophilic Esophagitis: Results from a post-hoc analysis of the randomized, double-blind, placebo-controlled EOS-1 trial

Stephan Miehlke, Christoph Schlag, Alex Straumann, Michael Vieth, Ralph Mueller, Roland Greinwald, Alfredo J. Lucendo

A PROSPECTIVE COHORT STUDY EVALUATING NAVIAID AB - A NOVEL PLATFORM FOR DEEP SMALL BOWEL ENTEROSCOPY

Helmut Neumann, Klaus Mönkemüller, Gian E. Tontini, Martin Grauer, Michael Vieth, Lucia Fry, Markus F. Neurath

HIGH-DEFINITION ENDOSCOPY WITH COMPUTED VIRTUAL CHROMOENDOSCOPY FOR PREDICTION OF FOOD ALLERGY IN REAL-TIME – A PROSPECTIVE, RANDOMIZED STUDY WITH CROSS-OVER DESIGN

Helmut Neumann, Michael Vieth, Gian E. Tontini, Steffen Zopf, Claudia Günther, Markus F. Neurath, Yurdagül Zopf

Item 1 - 10 / 57
1
2 3 4 5 6